Alternative Donor Transplantation—“Mixing and Matching”: the Role of Combined Cord Blood and Haplo-Identical Donor Transplantation (Haplo-Cord SCT) as a Treatment Strategy for Patients Lacking Standard Donors? Hongtao LiuKoen van Besien Stem Cell Transplantation (R Maziarz, Section Editor) 10 February 2015 Pages: 1 - 7
A Call to Arms: a Critical Need for Interventions to Limit Pulmonary Toxicity in the Stem Cell Transplantation Patient Population Sabarinath Venniyil RadhakrishnanGerhard C. Hildebrandt Stem Cell Transplantation (R Maziarz, Section Editor) 08 February 2015 Pages: 8 - 17
The Evolving Role of Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia Matthew S. DavidsEdwin P. Alyea Stem Cell Transplantation (R Maziarz, Section Editor) 15 February 2015 Pages: 18 - 27
Patient Selection for Allogeneic Hematopoietic Cell Transplantation (HCT): the Evolution of HCT Risk Assessment Lori Muffly Stem Cell Transplantation (R Maziarz, Section Editor) 11 December 2014 Pages: 28 - 34
Survivorship After Allogeneic Transplantation—Management Recommendations for the Primary Care Provider André TichelliAlicia Rovó Stem Cell Transplantation (R Maziarz, Section Editor) 10 February 2015 Pages: 35 - 44
Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime? Lara E. Sucheston-CampbellAlyssa ClayTheresa Hahn Stem Cell Transplantation (R Maziarz, Section Editor) Open access 21 February 2015 Pages: 45 - 58
Where Does Allogeneic Stem Cell Transplantation Fit in the Treatment of Chronic Lymphocytic Leukemia? Peter DregerEmili Montserraton behalf of the European Society for Blood and Marrow Transplantation (EBMT) and the European Research Initiative on CLL (ERIC) Chronic Lymphocytic Leukemias (S O’Brien, Section Editor) 05 February 2015 Pages: 59 - 64